HOME >> BIOLOGY >> NEWS
Scientists At The Scripps Research Institute And R.W. Johnson Pharmaceuticals Develop New Antibacterial Agents

La Jolla, CA. April 28, 1998 -- Scientists at The Scripps Research Institute (TSRI) and their colleagues at the R.W. Johnson Pharmaceutical Research Institute have developed a series of new antibacterial compounds designed specifically to target the biological mechanisms by which bacteria establish an infection in the host. With resistance to antibiotics an increasing public health threat, particularly in the hospital setting, the compounds offer the potential to provide protection against Staphylococcus aureus, or staph infection, vancomycin-resistant enterococci, and penicillin-resistant Staphylococcus pneumoniae.

According to the authors of the study, James A. Hoch, Ph.D., Professor, and John M. Whiteley, Associate Professor in the Department of Molecular and Experimental Medicine, "With infectious disease continuing to be our most serious health problem, this work represents important progress in a new target area for anti-infective therapy."

The study, "Antibacterial agents that inhibit two-component signal transduction systems," by J.F. Barrett, R.M. Goldschmidt, L.E. Lawrence, B. Foleno, R. Chen, J.P. Demers, S. Johnson, R. Kanojia, J. Fernandez, J. Bernstein, L. Licata, A. Donetz, S. Huang, D.J. Hlasta, M.J. Macielag, K. Ohemeng, R. Frechette, M.B. Frosco, D.H. Klaubert, J.M. Whiteley, L. Wang, and J.A. Hoch, appears in today's issue of Proceedings of the National Academy of Sciences, USA.

Due to the overuse of antibiotics and the failure of some patients to take a proper dosage of medication, resistance to antibiotics is becoming an increasing risk to public health. In May, 1997, the Centers for Disease Control and Prevention confirmed that Staphylococcus aureus had for the first time defended itself against vancomycin, the last drug reported to kill all of its strains. That strain, found in Japan, demonstrated an "intermediate" level of resistance to the antibiotic, a le
'"/>

Contact: Robin B. Goldsmith
rgoldsmi@scripps.edu
(619) 784-8134
Scripps Research Institute
28-Apr-1998


Page: 1 2

Related biology news :

1. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
2. Scientists sequence genome of kind of organism central to biospheres carbon cycle
3. Scientists find nanowires capable of detecting individual viruses
4. Scientists discover potential new way to control drug-resistant bacteria
5. Scientists explore genome of methane-breathing microbe
6. Scientists decipher genetic code of biothreat pathogen
7. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
8. Scientists discover proteins involved in spread of HIV-1 infection
9. Scientists fear new Ebola outbreak may explain sudden gorilla disappearance
10. Scientists reinvent DNA as template to produce organic molecules
11. Scientists visualise cellular handmaiden that restores shape to proteins

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2018)... ... 20, 2018 , ... When designing a fluidic system for ... ensure what is designed can be manufactured reliably and cost effectively while meeting ... path design with specific focus on layered manifold technology. , Layered manifold technology ...
(Date:8/17/2018)... N.J. and LIEGE, Belgium (PRWEB) , ... ... ... Diagenode today announced the acquisition of NXT-Dx, an established epigenetics service provider ... services including a number of targeted DNA methylation assays using pyrosequencing or ...
(Date:8/17/2018)... , ... August 16, 2018 , ... ... world’s first private cord blood bank to separate and store stem cells in ... Center, and Brian Sheehy, M.D. M.A. C.F.A., Founder and Managing Partner IsZo Capital, ...
Breaking Biology News(10 mins):
(Date:9/1/2018)... ... August 31, 2018 , ... Rudina Thanasi, ... of a proprietary biofield energy treated nutraceutical supplement used in combating inflammation and ... response and blood, as well as, organ-specific inflammation. The reported data is as ...
(Date:8/29/2018)... ... August 28, 2018 , ... Nanovis , an ... successful completion of a $5.5 million funding round managed by Commenda Securities. Key ... Capital, and Ellipsis Ventures. , “Our investment in Nanovis is consistent with our ...
(Date:8/29/2018)... ... August 28, 2018 , ... CEO and founder ... safety study performed on an allogeneic (donor derived) stem cell product for osteoarthritis ... conference in September. He is also the organizer of Breakout Session 4: ...
(Date:8/26/2018)... ... August 23, 2018 , ... ... engineers, and scientists from around the world, will host the 4th Annual Microbiology ... array of industries and disciplines, encompassing various research areas including medicine, agriculture, and ...
Breaking Biology Technology:
Cached News: